Study of ST266 Given by Intranasal Delivery in Glaucoma Suspect Subjects
Clinical trial NCT03901781 · COMPLETED
Trial details
- NCT number
- NCT03901781
- Sponsor
- Noveome Biotherapeutics, formerly Stemnion
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-23
- Primary completion
- 2022-05-20
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.